LNSR
LENSAR, Inc.
Price Chart
Latest Quote
$5.92
-0.14 (-2.31%)
Current Price
| Previous Close | $6.06 |
| Open | $6.09 |
| Day High | $6.09 |
| Day Low | $5.92 |
| Volume | 791 |
Stock Information
| Shares Outstanding | 12.28M |
| Total Debt | $2.57M |
| Cash Equivalents | $13.49M |
| Revenue | $57.70M |
| Net Income | $29.40M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $72.71M |
| EPS (TTM) | $-0.55 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $76.22M |
| Sales | $57.70M |
| Income | $29.40M |
| Book/sh | $0.89 |
| Cash/sh | $1.10 |
| Employees | 150 |
Financial Ratios
| Quick Ratio | 1.05 |
| Current Ratio | 2.38 |
| Debt/Eq | 10.47 |
Returns & Margins
| ROA | -14.73% |
| ROE | 362.55% |
| Gross Margin | 45.71% |
| Operating Margin | 49.24% |
| Profit Margin | 50.94% |
Ownership
| Insider Ownership | 21.53% |
| Institutional Ownership | 52.06% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -8.34 |
| P/S | 1.26 |
| P/B | 6.64 |
Analyst Data
| Recommendation | none |
| Target Price | $8.50 |
Technical Indicators
| SMA20 | $5.80 |
| SMA50 | $5.70 |
| SMA200 | $9.64 |
| RSI | 57.35 |
| ATR | 0.3076 |
| Shares Float | 8.68M |
| Short Float | 9.93% |
| Short Ratio | 14.85 |
| Volatility | 0.87 |
| Rel Volume | 0.02 |
Performance History
| Week | -5.43% |
| Month | -2.15% |
| Quarter | +6.09% |
| 6 Months | -50.87% |
| YTD | -49.01% |
| Year | -52.60% |
| 3 Years | +47.45% |
| 5 Years | -29.19% |
| 10 Years | -34.22% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $5.92 | 791 |
| 2026-06-24 | $6.06 | 132,300 |
| 2026-06-23 | $5.72 | 27,400 |
| 2026-06-22 | $5.66 | 67,300 |
| 2026-06-18 | $5.74 | 104,800 |
| 2026-06-17 | $6.26 | 54,200 |
| 2026-06-16 | $6.18 | 50,600 |
| 2026-06-15 | $5.72 | 58,500 |
| 2026-06-12 | $5.82 | 28,000 |
| 2026-06-11 | $5.82 | 54,800 |
| 2026-06-10 | $5.68 | 40,000 |
| 2026-06-09 | $5.69 | 22,400 |
| 2026-06-08 | $5.60 | 28,600 |
| 2026-06-05 | $5.60 | 47,400 |
| 2026-06-04 | $5.62 | 40,700 |
| 2026-06-03 | $5.74 | 52,700 |
| 2026-06-02 | $5.74 | 45,500 |
| 2026-06-01 | $5.67 | 44,600 |
| 2026-05-29 | $5.80 | 39,100 |
| 2026-05-28 | $6.00 | 38,600 |
| 2026-05-27 | $5.86 | 28,000 |
| 2026-05-26 | $6.05 | 28,100 |
About LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
đ° Latest News
How The LENSAR (LNSR) Story Is Shifting After The Failed Deal And New $10 Target
Simply Wall St. âĸ 2026-06-04T20:14:41Z
Lensar (LNSR) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-06-01T17:10:46Z
Lensar (LNSR) Q4 2025 Earnings Transcript
Motley Fool âĸ 2026-06-01T17:10:11Z
LENSAR Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-08T18:20:17Z
How The Failed Alcon Deal Is Reframing The LENSAR (LNSR) Story And $10 Upside Potential
Simply Wall St. âĸ 2026-04-21T05:03:24Z
Cedar Grove Capital Managementâs Views on LENSAR (LNSR)
Insider Monkey âĸ 2026-04-20T13:00:44Z
How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset
Simply Wall St. âĸ 2026-04-05T00:18:43Z
LENSAR Inc (LNSR) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges
GuruFocus.com âĸ 2026-04-04T01:00:45ZLENSAR, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-04-01T12:30:00Z
LENSAR Q4 Earnings Call Highlights
MarketBeat âĸ 2026-03-31T14:10:35Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $27,732,000 | $24,682,000 | $18,639,000 | $13,145,000 |
| Cost Of Revenue | $31,313,000 | $27,643,000 | $21,057,000 | $15,403,000 |
| Total Revenue | $58,435,000 | $53,494,000 | $42,164,000 | $35,358,000 |
| Operating Revenue | $58,435,000 | $53,494,000 | $42,164,000 | $35,358,000 |
| Expenses | ||||
| Total Expenses | $83,013,000 | $60,430,000 | $54,393,000 | $55,535,000 |
| Other Income Expense | $-9,702,000 | $-24,468,000 | $-2,154,000 | $263,000 |
| Other Non Operating Income Expenses | $636,000 | $660,000 | $698,000 | $263,000 |
| Operating Expense | $51,700,000 | $32,787,000 | $33,336,000 | $40,132,000 |
| Interest Expense | - | - | - | - |
| Net Non Operating Interest Income Expense | - | - | - | - |
| Interest Expense Non Operating | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-34,280,000 | $-31,404,000 | $-14,383,000 | $-19,914,000 |
| Normalized Income | $-23,942,000 | $-6,276,000 | $-11,531,000 | $-19,914,000 |
| Net Income From Continuing And Discontinued Operation | $-34,280,000 | $-31,404,000 | $-14,383,000 | $-19,914,000 |
| Total Operating Income As Reported | $-24,578,000 | $-10,665,000 | $-12,229,000 | $-20,177,000 |
| Net Income Common Stockholders | $-34,280,000 | $-31,404,000 | $-14,383,000 | $-19,914,000 |
| Net Income | $-34,280,000 | $-31,404,000 | $-14,383,000 | $-19,914,000 |
| Net Income Including Noncontrolling Interests | $-34,280,000 | $-31,404,000 | $-14,383,000 | $-19,914,000 |
| Net Income Continuous Operations | $-34,280,000 | $-31,404,000 | $-14,383,000 | $-19,914,000 |
| Pretax Income | $-34,280,000 | $-31,404,000 | $-14,383,000 | $-19,914,000 |
| Special Income Charges | $0 | $-3,729,000 | $0 | - |
| Operating Income | $-24,578,000 | $-6,936,000 | $-12,229,000 | $-20,177,000 |
| Depreciation Amortization Depletion Income Statement | $921,000 | $970,000 | $1,097,000 | $1,148,000 |
| Depreciation And Amortization In Income Statement | $921,000 | $970,000 | $1,097,000 | $1,148,000 |
| Amortization Of Intangibles Income Statement | $921,000 | $970,000 | $1,097,000 | $1,148,000 |
| Gross Profit | $27,122,000 | $25,851,000 | $21,107,000 | $19,955,000 |
| Net Interest Income | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-2.87 | $-2.73 | $-1.31 | $-1.96 |
| Basic EPS | $-2.87 | $-2.73 | $-1.31 | $-1.96 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-9,738,000 | $22,123,000 | $-5,862,000 | $-16,771,000 |
| Total Unusual Items | $-10,338,000 | $-25,128,000 | $-2,852,000 | - |
| Total Unusual Items Excluding Goodwill | $-10,338,000 | $-25,128,000 | $-2,852,000 | - |
| Reconciled Depreciation | $4,502,000 | $3,931,000 | $3,515,000 | $3,406,000 |
| EBITDA (Bullshit earnings) | $-20,076,000 | $-3,005,000 | $-8,714,000 | $-16,771,000 |
| EBIT | $-24,578,000 | $-6,936,000 | $-12,229,000 | $-20,177,000 |
| Diluted Average Shares | $11,958,000 | $11,518,000 | $10,971,000 | $10,159,000 |
| Basic Average Shares | $11,958,000 | $11,518,000 | $10,971,000 | $10,159,000 |
| Diluted NI Availto Com Stockholders | $-34,280,000 | $-31,404,000 | $-14,383,000 | $-19,914,000 |
| Impairment Of Capital Assets | $0 | $3,729,000 | $0 | - |
| Gain On Sale Of Security | $-10,338,000 | $-21,399,000 | $-2,852,000 | - |
| Amortization | $921,000 | $970,000 | $1,097,000 | $1,148,000 |
| Research And Development | $5,622,000 | $5,329,000 | $6,139,000 | $11,814,000 |
| Selling General And Administration | $45,157,000 | $26,488,000 | $26,100,000 | $27,170,000 |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-31,210,000 | $-1,250,000 | $22,404,000 | $29,862,000 |
| Total Assets | $71,430,000 | $66,297,000 | $69,585,000 | $55,844,000 |
| Total Non Current Assets | $24,659,000 | $24,318,000 | $23,141,000 | $22,128,000 |
| Other Non Current Assets | $2,747,000 | $2,615,000 | $2,207,000 | $2,685,000 |
| Non Current Note Receivables | $731,000 | $1,160,000 | $1,279,000 | $442,000 |
| Goodwill And Other Intangible Assets | $5,191,000 | $6,112,000 | $11,025,000 | $12,122,000 |
| Other Intangible Assets | $5,191,000 | $6,112,000 | $11,025,000 | $12,122,000 |
| Current Assets | $46,771,000 | $41,979,000 | $46,444,000 | $33,716,000 |
| Other Current Assets | $601,000 | $1,616,000 | $2,367,000 | $1,062,000 |
| Inventory | $21,520,000 | $11,428,000 | $15,689,000 | $11,740,000 |
| Receivables | $6,672,000 | $6,480,000 | $4,324,000 | $6,240,000 |
| Notes Receivable | $295,000 | $395,000 | $323,000 | $200,000 |
| Accounts Receivable | $6,377,000 | $6,085,000 | $4,001,000 | $6,040,000 |
| Allowance For Doubtful Accounts Receivable | $-62,000 | $-105,000 | $-62,000 | $-56,000 |
| Gross Accounts Receivable | $6,439,000 | $6,190,000 | $4,063,000 | $6,096,000 |
| Cash Cash Equivalents And Short Term Investments | $17,978,000 | $22,455,000 | $24,064,000 | $14,674,000 |
| Cash And Cash Equivalents | $12,974,000 | $16,263,000 | $20,621,000 | $14,674,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $2,735,000 | $2,614,000 | $2,309,000 | $2,803,000 |
| Long Term Debt And Capital Lease Obligation | $1,988,000 | $2,090,000 | $1,750,000 | $2,272,000 |
| Current Debt And Capital Lease Obligation | $747,000 | $524,000 | $559,000 | $531,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $97,449,000 | $61,435,000 | $36,156,000 | $13,860,000 |
| Total Non Current Liabilities Net Minority Interest | $56,875,000 | $46,432,000 | $24,524,000 | $2,439,000 |
| Other Non Current Liabilities | $909,000 | $702,000 | $570,000 | $167,000 |
| Derivative Product Liabilities | $40,194,000 | $29,856,000 | $8,457,000 | $0 |
| Current Liabilities | $40,574,000 | $15,003,000 | $11,632,000 | $11,421,000 |
| Other Current Liabilities | $10,000,000 | - | - | - |
| Current Deferred Liabilities | $3,074,000 | $1,677,000 | $1,349,000 | $939,000 |
| Payables And Accrued Expenses | $21,703,000 | $7,800,000 | $5,750,000 | $6,603,000 |
| Payables | $18,982,000 | $5,995,000 | $4,007,000 | $5,422,000 |
| Accounts Payable | $18,982,000 | $5,995,000 | $4,007,000 | $5,422,000 |
| Equity | ||||
| Common Stock Equity | $-26,019,000 | $4,862,000 | $33,429,000 | $41,984,000 |
| Total Equity Gross Minority Interest | $-26,019,000 | $4,862,000 | $33,429,000 | $41,984,000 |
| Stockholders Equity | $-26,019,000 | $4,862,000 | $33,429,000 | $41,984,000 |
| Gains Losses Not Affecting Retained Earnings | $4,000 | $6,000 | $4,000 | $0 |
| Other Equity Adjustments | $4,000 | $6,000 | $4,000 | - |
| Retained Earnings | $-177,575,000 | $-143,295,000 | $-111,891,000 | $-97,508,000 |
| Preferred Securities Outside Stock Equity | $13,784,000 | $13,784,000 | $13,747,000 | $0 |
| Other | ||||
| Ordinary Shares Number | $11,993,000 | $11,654,000 | $11,327,000 | $11,093,000 |
| Share Issued | $11,993,000 | $11,654,000 | $11,327,000 | $11,093,000 |
| Tangible Book Value | $-31,210,000 | $-1,250,000 | $22,404,000 | $29,862,000 |
| Invested Capital | $-26,019,000 | $4,862,000 | $33,429,000 | $41,984,000 |
| Working Capital | $6,197,000 | $26,976,000 | $34,812,000 | $22,295,000 |
| Capital Lease Obligations | $2,735,000 | $2,614,000 | $2,309,000 | $2,803,000 |
| Total Capitalization | $-26,019,000 | $4,862,000 | $33,429,000 | $41,984,000 |
| Additional Paid In Capital | $151,432,000 | $148,035,000 | $145,203,000 | $139,381,000 |
| Capital Stock | $120,000 | $116,000 | $113,000 | $111,000 |
| Common Stock | $120,000 | $116,000 | $113,000 | $111,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $1,988,000 | $2,090,000 | $1,750,000 | $2,272,000 |
| Current Deferred Revenue | $3,074,000 | $1,677,000 | $1,349,000 | $939,000 |
| Current Capital Lease Obligation | $747,000 | $524,000 | $559,000 | $531,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $5,050,000 | $5,002,000 | $3,974,000 | $3,348,000 |
| Current Accrued Expenses | $2,721,000 | $1,805,000 | $1,743,000 | $1,181,000 |
| Net PPE | $15,990,000 | $14,431,000 | $8,138,000 | $6,879,000 |
| Accumulated Depreciation | $-15,283,000 | $-14,028,000 | $-11,891,000 | $-10,694,000 |
| Gross PPE | $31,273,000 | $28,459,000 | $20,029,000 | $17,573,000 |
| Leases | $112,000 | $112,000 | $112,000 | $112,000 |
| Construction In Progress | $0 | $293,000 | $188,000 | $55,000 |
| Other Properties | $30,839,000 | $27,723,000 | $19,436,000 | $16,976,000 |
| Machinery Furniture Equipment | $322,000 | $331,000 | $293,000 | $430,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $4,622,000 | $2,936,000 | $4,936,000 | $4,002,000 |
| Work In Process | $4,153,000 | $1,292,000 | $2,395,000 | $797,000 |
| Raw Materials | $12,745,000 | $7,200,000 | $8,358,000 | $6,941,000 |
| Other Short Term Investments | $5,004,000 | $6,192,000 | $3,443,000 | $0 |
| Investments And Advances | - | $0 | $492,000 | $0 |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-14,914,000 | $-2,431,000 | $-9,895,000 | $-14,971,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-14,831,000 | $-2,275,000 | $-9,659,000 | $-14,856,000 |
| Cash Flow From Continuing Operating Activities | $-14,831,000 | $-2,275,000 | $-9,659,000 | $-14,856,000 |
| Operating Gains Losses | $10,396,000 | $21,399,000 | $2,859,000 | $11,000 |
| Investing Activities | ||||
| Capital Expenditure | $-83,000 | $-156,000 | $-236,000 | $-115,000 |
| Investing Cash Flow | $1,284,000 | $-2,161,000 | $-4,156,000 | $-115,000 |
| Cash Flow From Continuing Investing Activities | $1,284,000 | $-2,161,000 | $-4,156,000 | $-115,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $93,000 | $58,000 | $13,882,000 | $0 |
| Financing Cash Flow | $10,258,000 | $78,000 | $19,762,000 | $-1,992,000 |
| Cash Flow From Continuing Financing Activities | $10,258,000 | $78,000 | $19,762,000 | $-1,992,000 |
| Net Other Financing Charges | $10,000,000 | $-98,000 | - | $-2,400,000 |
| Net Common Stock Issuance | $93,000 | $58,000 | $0 | - |
| Common Stock Issuance | $93,000 | $58,000 | $0 | - |
| Net Preferred Stock Issuance | - | $0 | $13,882,000 | $0 |
| Preferred Stock Issuance | - | $0 | $13,882,000 | $0 |
| Cash Dividends Paid | - | - | - | - |
| Other | ||||
| Income Tax Paid Supplemental Data | $42,000 | $24,000 | $18,000 | $3,000 |
| End Cash Position | $12,974,000 | $16,263,000 | $20,621,000 | $14,674,000 |
| Beginning Cash Position | $16,263,000 | $20,621,000 | $14,674,000 | $31,637,000 |
| Changes In Cash | $-3,289,000 | $-4,358,000 | $5,947,000 | $-16,963,000 |
| Proceeds From Stock Option Exercised | $165,000 | $118,000 | $5,880,000 | $408,000 |
| Net Investment Purchase And Sale | $1,367,000 | $-2,005,000 | $-3,920,000 | $0 |
| Sale Of Investment | $13,245,000 | $8,240,000 | $0 | - |
| Purchase Of Investment | $-11,878,000 | $-10,245,000 | $-3,920,000 | $0 |
| Net PPE Purchase And Sale | $-83,000 | $-156,000 | $-236,000 | $-115,000 |
| Purchase Of PPE | $-83,000 | $-156,000 | $-236,000 | $-115,000 |
| Change In Working Capital | $1,101,000 | $-3,043,000 | $-7,778,000 | $-5,577,000 |
| Change In Other Working Capital | $1,561,000 | $591,000 | $975,000 | $-18,000 |
| Change In Other Current Liabilities | $-511,000 | $-559,000 | $-539,000 | $-512,000 |
| Change In Payables And Accrued Expense | $12,646,000 | $3,175,000 | $-525,000 | $2,825,000 |
| Change In Accrued Expense | $-341,000 | $1,219,000 | $892,000 | $96,000 |
| Change In Payable | $12,987,000 | $1,956,000 | $-1,417,000 | $2,729,000 |
| Change In Account Payable | $12,987,000 | $1,956,000 | $-1,417,000 | $2,729,000 |
| Change In Prepaid Assets | $1,015,000 | $751,000 | $-1,305,000 | $637,000 |
| Change In Inventory | $-13,899,000 | $-4,899,000 | $-7,461,000 | $-6,889,000 |
| Change In Receivables | $289,000 | $-2,102,000 | $1,077,000 | $-1,620,000 |
| Changes In Account Receivables | $-211,000 | $-2,189,000 | $2,057,000 | $-1,440,000 |
| Other Non Cash Items | $541,000 | $539,000 | $534,000 | $521,000 |
| Stock Based Compensation | $3,143,000 | $2,665,000 | $5,539,000 | $6,611,000 |
| Provisionand Write Offof Assets | $-53,000 | $65,000 | $1,000 | $36,000 |
| Asset Impairment Charge | $0 | $3,823,000 | $66,000 | $50,000 |
| Amortization Of Securities | $-181,000 | $-250,000 | $-12,000 | $0 |
| Depreciation Amortization Depletion | $4,502,000 | $3,931,000 | $3,515,000 | $3,406,000 |
| Depreciation And Amortization | $4,502,000 | $3,931,000 | $3,515,000 | $3,406,000 |
| Amortization Cash Flow | $921,000 | $970,000 | $1,097,000 | $1,148,000 |
| Amortization Of Intangibles | $921,000 | $970,000 | $1,097,000 | $1,148,000 |
| Depreciation | $3,581,000 | $2,961,000 | $2,418,000 | $2,258,000 |
| Gain Loss On Investment Securities | $10,338,000 | $21,399,000 | $2,852,000 | - |
| Gain Loss On Sale Of PPE | $58,000 | $0 | $7,000 | $11,000 |
| Net Income From Continuing Operations | $-34,280,000 | $-31,404,000 | $-14,383,000 | $-19,914,000 |
| Interest Paid Supplemental Data | - | - | - | $0 |
| Issuance Of Debt | - | - | - | - |
| Net Issuance Payments Of Debt | - | - | - | - |
| Net Long Term Debt Issuance | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
| Sale Of PPE | - | - | - | - |
Fetched: 2026-06-19